Sanofi (SNY) Tops Q1 EPS by EUR0.20
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Sanofi at forefront of fight against COVID-19 in Q1 2020
April 24, 2020 1:30 AM EDTSanofi at forefront of fight against COVID-19 in Q1 2020
Rapid and decisive response to COVID-19 global health crisis Sanofi showed resilience and maintained full business continuity worldwide including its global industrial network. Separate collaborations announced with BARDA, Translate Bio and GSK to develop novel COVID-19 vaccines.Global clinical program underway to evaluate Kevzara® in patients hospitalized with severe... More